Magnesium in cardiovascular disease

Journal of Clinical and Basic Cardiology

Volumn 5, Issue 1, 2002, Pages 55-59

  Stühlinger, H Georg ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Arrhythmia; Coronary artery disease; Magnesium

Indexed keywords

ANTIARRHYTHMIC AGENT; MAGNESIUM; NEUROLEPTIC AGENT; POTASSIUM; TRICYCLIC ANTIDEPRESSANT AGENT;

ATRIOVENTRICULAR CONDUCTION; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG OVERDOSE; HEART ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; MAGNESIUM DEFICIENCY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SINUS NODE; SUPRAVENTRICULAR TACHYCARDIA; THROMBOSIS; TORSADE DES POINTES;

EID: 0036234911     PISSN: 15612775     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Magnesium sulfate in paroxysmal tachycardia
2. The action of magnesium on the heart
3. Úber die magnesiumwirkung auf das herz
4. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans
5. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease
6. Modulation of cardiac impulse generation and conduction by nifedipine and verapamil analyzed by a refined surface ECG technique in Langendorff perfused guinea pig hearts
7. Role of magnesium for the treatment of cardiac arrhythmias
8. Hemodynamic effects of intravenously administered magnesium on patients with ischemic heart disease
9. The rationale of magnesium supplementation in acute myocardial infarction. A review of the literature
10. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects
11. Oral magnesium therapy improves endothelial function in patients with coronary artery disease
12. Oral magnesium supplementation improves exercise duration and quality of life in patients with coronary artery disease
13. Magnesium deficiency in a medical ICU population
14. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients
15. Efficacy of magnesium sulfate in the treatment of torsade de pointes
16. "Les torsades de pointes": An unusual ventricular arrhythmia
17. Polymorphous ventricular tachycardia associated with normal and long Q-T intervals
18. Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers
19. Treatment of torsade de pointes with magnesium sulfate
20. Magnesium therapy for torsades de pointes
21. Intravenous magnesium for the treatment of cardiac arrhythmias
22. The value of magnesium in intensive care medicine
23. Significance of magnesium in cardiac arrhythmias
24. The wider use of magnesium
25. Magnesium as an anti-arrhythmic therapy principle in supraventricular and ventricular cardiac arrhythmias
26. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: Advanced cardiovascular life support: Section 5: Pharmacology I: Agents for arrhythmias
27. Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium
28. Suppression of ventricular arrhythmias by magnesium
29. The effectiveness of magnesium choride in the treatment of ventricular tachyarrhythmias due to digitalis intoxication
30. Magnesium sulfate and digitalis-toxic arrhythmias
31. Magnesium sulfate in the treatment of ventricular arrhythmias due to digoxin toxicity
32. Magnesium therapy in massive digoxin intoxication
33. Magnesium therapy in ventricular arrhythmias
34. Magnesium and potassium therapy in multifocal atrial tachycardia
35. Magnesium and cardiac arrhythmias
36. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial
37. Magnesium substitution and postoperative arrhythmias in patients undergoing coronary artery bypass grafting
38. Myocardial tissue concentrations of magnesium and potassium in men dying suddenly from ischemic heart disease
39. Ventricular arrhythmia suppression by magnesium treatment after coronary artery bypass surgery
40. Arrhythmia prophylaxis after coronary artery bypass grafting: Regimens of magnesium sulfate administration
41. Magnesium sulphate in the treatment of ventricular fibrillation in amitriptyline poisoning
42. Case report: Reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication
43. Torsades de pointes ventricular tachycardia associated with overdose of astemizole
44. Arrhythmogenic effect of flecainide-treatment with i.v. magnesium
45. Magnesium therapy for refractory ventricular fibrillation
46. Successful resuscitation and neurologic recovery from refractory ventricular fibrillation after magnesium sulfate administration
47. Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia
48. Limited effectiveness of magnesium infusions for suppressing inducible sustained monomorphic ventricular tachycardia
49. Electrophysiologic and antiarrhythmic effects of magnesium in patients with inducible ventricular tachyarrhythmia
50. A double blind randomized trial of magnesium sulfate for ventricular tachycardia
51. Magnesium: Einfluß einer hochdosierten intravenösen applikation auf monomorphe ventrikuläre tachykardien
52. Effect of intravenous magnesium sulfate on supraventricular tachycardia
53. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia
54. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate
55. Magnesium and the heart: Antiarrhythmic therapy with magnesium
56. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure
57. Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias
58. Effects of intravenous magnesium sulfate on arrhythmias in patients with congestive heart failure
59. Is oral magnesium replacement antiarrhythmic in patients with congestive heart failure?
60. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: The PROMISE Study
61. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation
62. Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure
63. Potassium/magnesium depletion in patients with cardiovascular disease
64. Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment
65. Magnesium deficiency and magnesium substitution. Effect on ventricular cardiac arrhythmias of various etiology
66. Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin
67. Magnesium therapy in new-onset atrial fibrillation
68. The effect of magnesium versus verapamil on supraventricular arrhythmias
69. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: A prospective, randomized study
70. Effect of magnesium Effect sulfate on ventricular rate control in atrial fibrillation
71. Resuscitation from prolonged cardiac arrest with high-dose intravenous magnesium sulfate
72. Magnesium in cardiac arrest (the magic trial)
73. Randomised trial of magnesium in in-hospital cardiac arrest
74. Limited effect of magnesium sulphate on torsades de pointes ventricular tachycardia
75. High-dosage oral magnesium therapy in arrhythmias. Results of an observational study in 1.160 patients with arrhythmia
76. Oral magnesium reduces ventricular ectopy in digitalised patients with chronic atrial fibrillation
77. Die wirkung einer oralen magnesiumsupplementation auf ventrikuläre arrhythmien und parameter des magnesiumstoffwechsels
78. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation
79. Letter: Ischemic heart disease, water hardness and myocardial magnesium
80. Heart-muscle magnesium, potassium, and zinc concentrations after sudden death from heart-disease
81. Dietary intake levels and requirements of Mg and Ca for different segments of the U.S. population
82. Water hardness, arteriosclerotic heart disease and sudden death
83. Soft water, heart attacks, and stroke
84. Intracellular magnesium predicts functional capacity in patients with coronary artery disease
85. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study
86. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease
87. Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease
88. Survival 12 years after randomization to streptokinase: The influence of thrombolysis in myocardial infarction flow at three to four weeks
89. Review of clinical evidence-is there a role for supplemental magnesium in acute myocardial infarction in high-risk populations (patients ineligible for thrombolysis and the elderly)?
90. Magnesium: Nature's physiologic calcium blocker
91. Magnesium and glucose homeostasis